- Home
- TLSI vs STRW Comparison
TLSI vs STRW Comparison
Compare TLSI & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- STRW
- Stock Information
- Founded
- TLSI 2010
- STRW 2015
- Country
- TLSI United States
- STRW United States
- Employees
- TLSI N/A
- STRW N/A
- Industry
- TLSI Medical Specialities
- STRW Real Estate Investment Trusts
- Sector
- TLSI Health Care
- STRW Real Estate
- Exchange
- TLSI Nasdaq
- STRW Nasdaq
- Market Cap
- TLSI 160.4M
- STRW 133.6M
- IPO Year
- TLSI N/A
- STRW N/A
- Fundamental
- Price
- TLSI $5.21
- STRW $10.25
- Analyst Decision
- TLSI Strong Buy
- STRW Strong Buy
- Analyst Count
- TLSI 5
- STRW 4
- Target Price
- TLSI $10.90
- STRW $13.83
- AVG Volume (30 Days)
- TLSI 41.1K
- STRW 47.3K
- Earning Date
- TLSI 05-15-2025
- STRW 05-09-2025
- Dividend Yield
- TLSI N/A
- STRW 5.60%
- EPS Growth
- TLSI N/A
- STRW 34.22
- EPS
- TLSI N/A
- STRW 0.58
- Revenue
- TLSI $32,141,000.00
- STRW $126,557,000.00
- Revenue This Year
- TLSI $55.13
- STRW $15.21
- Revenue Next Year
- TLSI $50.71
- STRW $2.21
- P/E Ratio
- TLSI N/A
- STRW $17.34
- Revenue Growth
- TLSI 46.20
- STRW 22.41
- 52 Week Low
- TLSI $3.50
- STRW $8.70
- 52 Week High
- TLSI $7.55
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- TLSI 46.54
- STRW 47.46
- Support Level
- TLSI $4.95
- STRW $9.46
- Resistance Level
- TLSI $5.68
- STRW $10.75
- Average True Range (ATR)
- TLSI 0.40
- STRW 0.65
- MACD
- TLSI 0.01
- STRW 0.04
- Stochastic Oscillator
- TLSI 39.74
- STRW 54.20
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.